Login to view video
Video

Do more HMOs translate into increased benefits?

Allergy
Gut Microbiota
Growth & Development

The more we learn about human milk oligosaccharides (HMOs), the greater the evidence becomes that they are essential for  balanced nutrition during infancy. Since approximately 5 years ago it became possible to industrially produce 2’fucosyllactose (2’FL), in an identical structure to the 2’FL present in mother’s milk. As could be predicted, more HMOs can now be synthetized, resulting in the availability of blend of 5 HMOs (2’FL, difucosyllactose (DFL), Lacto-N-tetraose (LNT), 3’-Sialyllactose (3’SL) which have been shown to be safe and well tolerated in infants.

Author(s): Yvan Vandenplas

Prof. Yvan Vandenplas
Yvan Vandenplas

Presented at

6th World Congress of Pediatric Gastroenterology, Hepatology and Nutrition (WCPGHAN) 2021

If you liked this post you may also like

Please log in to your profile so we can show recommended content.